Navigating Market Changes: Piramal Pharma's Growth and Key Industry Trends

Stu Needleman, Chief Commercial Officer at Piramal Pharma Solutions, discusses the Biosecure Act and other big trends shaking up the industry, including GLP-1s, consolidation in the CDMO sector, and sterile fill-finish. He tells us more about Piramal’s $80-million expansion in Kentucky and how the company is adapting to the changes in the market. Check out the video!

---------------------
Read more of our articles here: https://themedicinemaker.com/
Sign up for free digital & physical copies here: https://themedicinemaker.com/login/si...

This film was created by Texere Video Production. To find out more visit our website.
To discuss your own video needs contact our team at
[email protected]

Subscribe to The Medicine Maker official YouTube channel here: https://bit.ly/3aXH6EP

Press the bell button to receive notifications whenever we post a new video.

Follow us and access our latest content:
Twitter: https://bit.ly/3C3coWV
Facebook: https://bit.ly/3vBcBye
Linkedin: https://bit.ly/3vKTulr
Instagram: https://bit.ly/3jlzOPK
Website: https://bit.ly/30MUQR8

To follow what we are doing at Texere follow us:
Twitter: https://bit.ly/3nfDZ0P
Facebook: https://bit.ly/3AZ9fWI
Linkedin: https://bit.ly/3b1ZHj6
Instagram: https://bit.ly/3E8BoMO
Website: https://bit.ly/3B51GxG